IMJUDO 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Astrazeneca Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 09f43811cd43edd4
Drug Cima Aemps Name: IMJUDO 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1221713002
Holder Company Name: Astrazeneca Ab
Marketing Company Name: Astrazeneca Farmaceutica Spain S.A.
Holder Company Detail Path: /organization/astrazeneca-ab
Authorization Date: 2023-03-01
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 300 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Astrazeneca Ab
Company Detail Path: /organization/astrazeneca-ab

TREMELIMUMAB

300 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 1, 2023

Approval ID

09f43811cd43edd4

Type

Standard